WHEREIN R1 IS HYDROGEN ATOM OR A LOWER ALKYL; R2 IS LOWER ALKYL; R3 IS AN UNSUBSTITUTED OR SUBSTITUTED PHENYL OR BENZYL RADICAL, THE SUBSTITUENTS, WHEN PRESENT, BEING HALOGEN OR LOWER ALKYL OR ALKOXY GROUPS, AND N IS 1, 2 OR 3, AND THE PHARMACOLOGICALLY COMPATIBLE SALTS THEREOF; HAVE OUTSTANDING ANTI-OEDEMATOUS ACTIVITY AND REDUCE INCREASED CAPILLARY PERMEABILITY.
摘要:
Novel phenoxyalkyl-carboxylic acid derivatives of the formula
wherein R1 and R2, which may be the same or different, are hydrogen or methyl; N IS 1 OR 2; Z is hydroxyl or alkoxy; and Y is a 5- or 6-membered heterocyclic ring containing, as hetero atoms, 1 or 2 sulfur, oxygen or nitrogen atoms, which heterocyclic ring may be substituted by halogen atoms or lower alkyl, alkoxy or alkoxyalkoxy radicals and may also contain a fused benzene nucleus, which can be substituted by halogen atoms or alkoxy or an alkylene radical; AND THE PHARMOCOLOGICALLY COMPATIBLE SALTS THEREOF, ARE OUTSTANDINGLY EFFECTIVE AS SERUM LIPID DEPRESSANTS AND ARE THUS EFFECTIVE THERAPEUTIC AGENTS IN THE TREATMENT OF ATHEROSCLEROSIS.
摘要翻译:式R1 | Y-CO-NH-(CH2)n -O-C-CO-Z | R2的新型苯氧基烷基 - 羧酸衍生物,其中可以相同或不同的R 1和R 2是氢或甲基; N IS 1 OR 2; Z是羟基或烷氧基; Y为5或6元杂环,杂环为1或2个硫,氧或氮原子,该杂环可被卤素原子或低级烷基,烷氧基或烷氧基烷氧基取代,也可含有 稠合的苯核,其可以被卤素原子或烷氧基或亚烷基取代; 并且其药理学兼容的盐,作为血清脂质沉着剂是非常有效的,并且是有效的治疗药物治疗甲状腺功能亢进症。